NIH Appoints Dr. Paul Coates to Head Office of Dietary Supplements
Office of Communications and Public Liaison
The National Institutes of Health (NIH) announced today the appointment of Paul M. Coates, Ph.D. as the new Director of NIH’s Office of Dietary Supplements effective October 25, 1999.
Dr. Coates served from 1996-1999 as Deputy Director of the Division of Nutrition Research Coordination (DNRC) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In that role, Dr. Coates helped to coordinate human nutrition research efforts, both at the NIH and between the NIH and other government agencies. Among these efforts is Healthy People 2010, the DHHS initiative to set public health goals for the nation. Dr. Coates co-leads the development of the Nutrition/Overweight chapter for which he received the NIH Director’s Award for outstanding activities. He also serves on the Federal Steering Committee that oversees the development of the Dietary Reference Intakes.
Prior to joining the DNRC, Dr. Coates was NIDDK’s Program Director for the Type 2 Diabetes Research Program (1993-1996) and Project Officer for the multi-center clinical study called Epidemiology of Diabetes Interventions and Complications (1994-1996). From 1994 until his departure from NIDDK, he maintained an active interest in career development and fellowship training in the Division of Diabetes, Endocrinology, and Metabolic Diseases.
Before coming to the NIH, Dr. Coates was on the faculty of the University of Pennsylvania School of Medicine and the Children’s Hospital of Philadelphia (1975-1993), where he was Research Professor in the Department of Pediatrics and Biochemistry/Biophysics. His Ph.D. degree in human genetics was from Queen’s University in Canada (1972) and his postdoctoral training took place in the Department of Human Genetics and Biometry at University College London (1972-1974).
His major research interests for many years focused on inborn errors of human lipid metabolism. Dr. Coates conducted some of the early studies of fatty acid oxidation disorders in infants and children. With an international team of collaborators, he was responsible for defining many of the genetic defects of human mitochondrial fatty acid oxidation. He also has studied the metabolism of intestinal and hepatic lipoproteins in people, to identify the metabolic defects in inherited hyperlipidemias. These studies have led to a new understanding of the role of environmental factors, such as diet, in the manifestation of genetic disease. He has written more than 100 publications, and has edited two books in these areas of research.
The Office of Dietary Supplements (ODS) was established in November 1995 within the Office of the Director at NIH. The mission of ODS is to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, stimulating and supporting research, disseminating research results, and educating the public to foster an enhanced quality of life and health for the U.S. population.